HYRNUCO
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99237033
- Mark type
- Stylized text
- Filed
- 16 Jun 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Parkinson’s disease; Pharmaceutical preparations for the treatment of and prevention of cardiovascular diseases; Pharmaceutical preparations for the treatment of and prevention of inflammation; Pharmaceutical preparations for the treatment of cancer
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
Prosecution history
- 25 Feb 2026 — TEAS DELETE 1(B) BASIS RECEIVED
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Nov 2025 — ASSIGNED TO LIE
- 11 Nov 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 06 Sept 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 06 Sept 2025 — LETTER OF SUSPENSION E-MAILED
- 06 Sept 2025 — SUSPENSION LETTER WRITTEN
- 06 Sept 2025 — ASSIGNED TO EXAMINER
- 16 Jun 2025 — APPLICATION FILING RECEIPT MAILED